Flu jabs halve threat of embolism in under-50s
Having a flu jab could almost halve the risk of developing venous thromboembolisms (VTE) among the under 50s, according to French research. The findings, presented at the annual AHA scientific sessions are the first to show that influenza vaccination can offer protection against VTEs, suc
Exercise can cut heart failure mortality risk - ALWAYS CHECK WITH YOUR OWN DOCTOR
Working out on a stationary bicycle or walking on a treadmill just 25 to 30 minutes daily can modestly reduce hospitalisation or death risk in
The HF-ACTION trial (A Controlled Trial Investigating Outcomes Exercise Training) led by Dr Christopher O'Connor, director of the Duke Heart Centre showed that exercising improved outcomes for patients who have suffered heart failure.
Researchers look at sildenafil use in cirrhosis patients
Sildenafil is valuable in the treatment of erectile dysfunction and pulmonary hypertension in patients with end-stage liver disease through inhibition of the type-5 phosphodiesterase. The type-5 phosphodiesterase is also present in human mesenteric arteries.
Plavix plus Heartburn Drugs Boost Patients’ Risk for Cardiac Events
A Medco Health Solutions study presented Tuesday at the American Heart Association meeting in New Orleans reveals that stent patient taking Sanofi-Aventis/Bristol-Myers Squibb’s blood thinner block buster Plavix or clopidogrel along with certain heartburn drugs such as AstraZeneca PLC's Nexium may face a greater risk of heart attack, stroke and other dangerous events than those who took Plavix alone.
Gender Matching Aids Long-term Survival After Heart Transplants
ScienceDaily (Nov. 13, 2008) — Gender matching between donors and recipients is important to short- and long-term survival in heart transplantation, according to a retrospective study presented at the American Heart Association’s Scientific Sessions 2008.
FDA (USA) Warns on Mexican Vanilla and warfarin ( coumadin)
The FDA is advising consumers to be cautious when buying vanilla in Mexico and other Latin American countries, to look for “vanilla bean” on the label’s ingredient list, and to not buy the product if it says “tonka bean” or has a vague ingredient list or no list.
Patients With PAH Who Discontinue Other Medications Due to Liver Abnormalities Fare Well With Ambrisentan
PHILADELPHIA -- November 4, 2008 -- Ambrisentan is a potential treatment for patients with pulmonary arterial hypertension (PAH) who fail to respond to other endothelin receptor antagonists due to liver function test abnormalities, according to researchers speaking here at CHEST 2008, the annual meeting of the American College of Chest Physicians.
Injection of stem cells into heart with catheter is tested- USA
If the early-stage research bears fruit, it could make repair from heart attacks much simpler, more widely available and cheaper, possibly replacing open heart surgery and heart transplants with an outpatient procedure, said Joshua Hare, the cardiologist who performed the procedure.
THIS IS NOT PH RELATED BUT IT IS A START............
Scleroderma Foundation Launches ECHO National Education Campaign at American College of Rheumatology Annual Meeting
Program encourages yearly echocardiograms to diagnose the estimated 25 - 40 percent of scleroderma patients (100,000 individuals) who have or will develop PAH(i) DANVERS, Mass., Oct. 24
Drug Combo Relieves Symptoms in Pulmonary Hypertension
CLAMART, France, Oct. 20 -- Combining sildenafil (Revatio) and epoprostenol (Flolan) significantly improved exercise capacity in some patients with pulmonary hypertension, researchers said here.